| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Adrenal Insufficiency | 4 | 2020 | 190 | 1.54 | Why? |
| Phosphodiesterase 5 Inhibitors | 9 | 2020 | 104 | 1.40 | Why? |
| Testosterone | 12 | 2020 | 596 | 1.38 | Why? |
| Klinefelter Syndrome | 7 | 2019 | 21 | 1.28 | Why? |
| Infertility, Male | 13 | 2019 | 322 | 1.26 | Why? |
| Spermatozoa | 10 | 2020 | 244 | 1.18 | Why? |
| Hormone Replacement Therapy | 4 | 2020 | 146 | 1.12 | Why? |
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 5 | 2020 | 24 | 0.89 | Why? |
| Hypogonadism | 8 | 2019 | 196 | 0.88 | Why? |
| Insulin-Like Growth Factor I | 3 | 2017 | 119 | 0.85 | Why? |
| Human Growth Hormone | 3 | 2019 | 120 | 0.83 | Why? |
| Obesity | 16 | 2021 | 7388 | 0.80 | Why? |
| Hirsutism | 1 | 2018 | 15 | 0.74 | Why? |
| Contraceptives, Oral, Combined | 1 | 2018 | 20 | 0.73 | Why? |
| Tosyl Compounds | 1 | 2018 | 45 | 0.72 | Why? |
| Anilides | 1 | 2018 | 105 | 0.68 | Why? |
| Impulsive Behavior | 1 | 2017 | 78 | 0.65 | Why? |
| Growth Disorders | 1 | 2017 | 91 | 0.65 | Why? |
| Psychopathology | 1 | 2017 | 107 | 0.65 | Why? |
| Fertility | 6 | 2018 | 367 | 0.64 | Why? |
| Glucocorticoids | 4 | 2020 | 4431 | 0.62 | Why? |
| Polycystic Ovary Syndrome | 1 | 2018 | 151 | 0.59 | Why? |
| Semen | 6 | 2021 | 550 | 0.58 | Why? |
| Nutrition Assessment | 2 | 2018 | 527 | 0.55 | Why? |
| Muscle, Skeletal | 6 | 2018 | 915 | 0.54 | Why? |
| Steroids | 1 | 2020 | 904 | 0.54 | Why? |
| Androgen Antagonists | 1 | 2018 | 404 | 0.53 | Why? |
| Testicular Neoplasms | 3 | 2019 | 91 | 0.52 | Why? |
| Hydrocortisone | 3 | 2020 | 1790 | 0.52 | Why? |
| Sildenafil Citrate | 5 | 2019 | 66 | 0.52 | Why? |
| Body Composition | 7 | 2018 | 414 | 0.51 | Why? |
| Body Mass Index | 9 | 2019 | 4306 | 0.51 | Why? |
| Overweight | 4 | 2021 | 916 | 0.49 | Why? |
| Nitriles | 1 | 2018 | 1053 | 0.49 | Why? |
| Cadmium | 3 | 2018 | 105 | 0.46 | Why? |
| Spermatogenesis | 5 | 2019 | 126 | 0.46 | Why? |
| Cryopreservation | 3 | 2020 | 464 | 0.46 | Why? |
| Diabetes Mellitus, Type 2 | 12 | 2019 | 6166 | 0.46 | Why? |
| Biomarkers | 12 | 2020 | 23361 | 0.45 | Why? |
| Sexual Dysfunctions, Psychological | 2 | 2018 | 37 | 0.45 | Why? |
| Nutritional Status | 2 | 2018 | 1403 | 0.42 | Why? |
| Semen Preservation | 2 | 2020 | 41 | 0.40 | Why? |
| Penile Erection | 3 | 2018 | 58 | 0.39 | Why? |
| Andrology | 3 | 2020 | 126 | 0.38 | Why? |
| General Practice | 1 | 2018 | 718 | 0.38 | Why? |
| Weight Loss | 4 | 2018 | 826 | 0.37 | Why? |
| Erectile Dysfunction | 4 | 2018 | 141 | 0.37 | Why? |
| Varicocele | 2 | 2017 | 11 | 0.36 | Why? |
| Aneuploidy | 2 | 2018 | 27 | 0.36 | Why? |
| Tadalafil | 2 | 2017 | 18 | 0.35 | Why? |
| Androgens | 3 | 2017 | 267 | 0.35 | Why? |
| Neoplasms, Germ Cell and Embryonal | 2 | 2019 | 106 | 0.34 | Why? |
| Sperm Injections, Intracytoplasmic | 2 | 2017 | 87 | 0.34 | Why? |
| Cystic Fibrosis | 1 | 2017 | 1104 | 0.34 | Why? |
| Bone Density | 4 | 2018 | 335 | 0.33 | Why? |
| Endocrinology | 3 | 2020 | 252 | 0.33 | Why? |
| Anthropometry | 2 | 2018 | 233 | 0.33 | Why? |
| Receptors, Calcitriol | 2 | 2017 | 102 | 0.31 | Why? |
| Muscle Fibers, Skeletal | 2 | 2016 | 31 | 0.31 | Why? |
| Sperm Motility | 4 | 2019 | 106 | 0.31 | Why? |
| Bone and Bones | 2 | 2018 | 235 | 0.29 | Why? |
| Metabolic Syndrome | 4 | 2018 | 810 | 0.29 | Why? |
| Cyclic GMP | 3 | 2020 | 50 | 0.29 | Why? |
| DNA Fragmentation | 3 | 2019 | 67 | 0.28 | Why? |
| Insulin Resistance | 6 | 2019 | 669 | 0.27 | Why? |
| Leydig Cells | 2 | 2018 | 29 | 0.27 | Why? |
| Phosphodiesterase Inhibitors | 1 | 2004 | 61 | 0.26 | Why? |
| Male | 79 | 2021 | 367725 | 0.26 | Why? |
| Lipid Metabolism | 2 | 2019 | 572 | 0.26 | Why? |
| Semen Analysis | 6 | 2020 | 235 | 0.25 | Why? |
| Energy Metabolism | 2 | 2017 | 451 | 0.25 | Why? |
| Quality of Life | 5 | 2018 | 9820 | 0.25 | Why? |
| Antibodies | 2 | 2001 | 846 | 0.25 | Why? |
| Inflammation Mediators | 3 | 2018 | 2654 | 0.25 | Why? |
| Diabetes, Gestational | 2 | 2019 | 426 | 0.24 | Why? |
| Autoimmunity | 2 | 2018 | 841 | 0.24 | Why? |
| Autoantibodies | 4 | 2018 | 2094 | 0.24 | Why? |
| Diabetes Mellitus | 3 | 2021 | 8207 | 0.24 | Why? |
| Orgasm | 2 | 2018 | 20 | 0.24 | Why? |
| Osteoprotegerin | 2 | 2018 | 32 | 0.24 | Why? |
| Receptors, Androgen | 3 | 2017 | 212 | 0.24 | Why? |
| Interleukin-8 | 2 | 2018 | 964 | 0.23 | Why? |
| Follicle Stimulating Hormone | 2 | 2019 | 73 | 0.23 | Why? |
| Addison Disease | 2 | 2018 | 24 | 0.23 | Why? |
| Circadian Rhythm | 2 | 2018 | 607 | 0.23 | Why? |
| Follow-Up Studies | 14 | 2020 | 17020 | 0.23 | Why? |
| Antioxidants | 1 | 2011 | 1593 | 0.22 | Why? |
| Muscle Cells | 2 | 2017 | 40 | 0.22 | Why? |
| Myocytes, Cardiac | 2 | 2018 | 804 | 0.22 | Why? |
| Environmental Pollutants | 2 | 2017 | 320 | 0.22 | Why? |
| Hashimoto Disease | 2 | 2018 | 74 | 0.21 | Why? |
| Piperazines | 1 | 2004 | 445 | 0.21 | Why? |
| Hypothalamo-Hypophyseal System | 2 | 2020 | 187 | 0.21 | Why? |
| Leydig Cell Tumor | 1 | 2019 | 4 | 0.21 | Why? |
| Sexual Behavior | 3 | 2018 | 1322 | 0.21 | Why? |
| Ceramics | 2 | 2019 | 26 | 0.21 | Why? |
| Humans | 106 | 2021 | 930598 | 0.21 | Why? |
| Adult | 47 | 2021 | 244371 | 0.21 | Why? |
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2019 | 3 | 0.20 | Why? |
| Angiopoietin-1 | 1 | 2019 | 25 | 0.20 | Why? |
| Vasoactive Intestinal Peptide | 1 | 2019 | 6 | 0.20 | Why? |
| Chromosomes, Human, Y | 1 | 2019 | 24 | 0.20 | Why? |
| Thyroid Hormones | 2 | 2018 | 213 | 0.20 | Why? |
| Membrane Lipids | 1 | 2000 | 91 | 0.20 | Why? |
| Extraembryonic Membranes | 1 | 2019 | 19 | 0.20 | Why? |
| Orchiectomy | 1 | 2019 | 63 | 0.20 | Why? |
| Hardness | 1 | 2018 | 4 | 0.20 | Why? |
| Fatty Acids, Unsaturated | 1 | 2000 | 70 | 0.20 | Why? |
| Insulin | 3 | 2017 | 1316 | 0.20 | Why? |
| Somatostatin | 1 | 2019 | 49 | 0.20 | Why? |
| Intra-Abdominal Fat | 2 | 2019 | 227 | 0.20 | Why? |
| Masturbation | 1 | 2018 | 13 | 0.19 | Why? |
| Chromosome Deletion | 1 | 2019 | 62 | 0.19 | Why? |
| Diet, Ketogenic | 1 | 2021 | 109 | 0.19 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.19 | Why? |
| Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2018 | 2 | 0.19 | Why? |
| Recycling | 1 | 2019 | 71 | 0.19 | Why? |
| Receptors, Steroid | 1 | 2018 | 31 | 0.19 | Why? |
| Bone Morphogenetic Proteins | 1 | 2018 | 25 | 0.19 | Why? |
| Fertility Preservation | 1 | 2020 | 121 | 0.19 | Why? |
| Doping in Sports | 1 | 2018 | 45 | 0.19 | Why? |
| Gastritis, Atrophic | 1 | 2018 | 20 | 0.19 | Why? |
| CLOCK Proteins | 1 | 2018 | 24 | 0.19 | Why? |
| Ataxia Telangiectasia | 1 | 2018 | 12 | 0.19 | Why? |
| Procollagen | 1 | 2018 | 29 | 0.19 | Why? |
| Sex Chromosomes | 1 | 2018 | 8 | 0.19 | Why? |
| Receptors, Thyroid Hormone | 1 | 2017 | 3 | 0.19 | Why? |
| Asthenozoospermia | 1 | 2017 | 18 | 0.18 | Why? |
| Ataxia Telangiectasia Mutated Proteins | 1 | 2018 | 48 | 0.18 | Why? |
| rho GTP-Binding Proteins | 1 | 2017 | 18 | 0.18 | Why? |
| Endocrine Disruptors | 1 | 2018 | 50 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.18 | Why? |
| Preimplantation Diagnosis | 1 | 2017 | 16 | 0.18 | Why? |
| Urinalysis | 1 | 2020 | 218 | 0.18 | Why? |
| Fetal Heart | 1 | 2018 | 46 | 0.18 | Why? |
| Neovascularization, Physiologic | 1 | 2019 | 160 | 0.18 | Why? |
| Endarterectomy, Carotid | 1 | 2018 | 78 | 0.18 | Why? |
| Hypoparathyroidism | 1 | 2018 | 36 | 0.18 | Why? |
| Chromatin | 1 | 2019 | 107 | 0.18 | Why? |
| Acromegaly | 1 | 2019 | 79 | 0.18 | Why? |
| Premature Ejaculation | 1 | 2017 | 3 | 0.18 | Why? |
| Sexuality | 1 | 2018 | 85 | 0.18 | Why? |
| Heart Rate | 2 | 2018 | 1527 | 0.18 | Why? |
| Italy | 12 | 2021 | 38444 | 0.18 | Why? |
| Selenomethionine | 1 | 2017 | 9 | 0.18 | Why? |
| Bone Morphogenetic Protein 7 | 1 | 2017 | 5 | 0.18 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.18 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2018 | 907 | 0.18 | Why? |
| Receptor for Advanced Glycation End Products | 1 | 2019 | 100 | 0.18 | Why? |
| Diabetic Cardiomyopathies | 1 | 2018 | 79 | 0.17 | Why? |
| Sperm Retrieval | 1 | 2017 | 18 | 0.17 | Why? |
| Phospholipids | 1 | 2000 | 202 | 0.17 | Why? |
| Female | 45 | 2021 | 380317 | 0.17 | Why? |
| Basal Metabolism | 1 | 2017 | 47 | 0.17 | Why? |
| Pathology, Molecular | 1 | 2021 | 343 | 0.17 | Why? |
| Osteopontin | 1 | 2018 | 96 | 0.17 | Why? |
| Foscarnet | 1 | 2017 | 13 | 0.17 | Why? |
| Thyroid Carcinoma, Anaplastic | 1 | 2017 | 16 | 0.17 | Why? |
| Anorexia | 1 | 2018 | 194 | 0.17 | Why? |
| Adrenal Gland Neoplasms | 1 | 2018 | 70 | 0.17 | Why? |
| Weight Reduction Programs | 1 | 2018 | 87 | 0.17 | Why? |
| Denosumab | 1 | 2017 | 49 | 0.17 | Why? |
| Abdominal Fat | 1 | 2017 | 43 | 0.17 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2017 | 83 | 0.17 | Why? |
| Myocytes, Smooth Muscle | 2 | 2018 | 127 | 0.17 | Why? |
| Homeostasis | 3 | 2017 | 582 | 0.17 | Why? |
| Calcium-Binding Proteins | 1 | 2017 | 121 | 0.17 | Why? |
| Middle Aged | 41 | 2021 | 270681 | 0.17 | Why? |
| Blastocyst | 1 | 2017 | 65 | 0.17 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2018 | 286 | 0.16 | Why? |
| Chromosomes, Human, X | 1 | 2017 | 81 | 0.16 | Why? |
| Osteoporosis, Postmenopausal | 1 | 2017 | 75 | 0.16 | Why? |
| Testis | 2 | 2019 | 566 | 0.16 | Why? |
| Intelligence | 1 | 2017 | 89 | 0.16 | Why? |
| Personality Disorders | 1 | 2017 | 81 | 0.16 | Why? |
| Cardiomegaly | 1 | 2017 | 96 | 0.16 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.16 | Why? |
| Rest | 1 | 2017 | 188 | 0.16 | Why? |
| Calcitriol | 1 | 2016 | 84 | 0.16 | Why? |
| Phenotype | 5 | 2019 | 4037 | 0.16 | Why? |
| HMGB1 Protein | 1 | 2019 | 223 | 0.16 | Why? |
| Exercise Test | 3 | 2018 | 911 | 0.16 | Why? |
| Cardiovascular Diseases | 7 | 2020 | 11497 | 0.16 | Why? |
| Pericardium | 1 | 2019 | 228 | 0.16 | Why? |
| Translations | 1 | 2017 | 153 | 0.16 | Why? |
| Glucose Intolerance | 1 | 2017 | 115 | 0.16 | Why? |
| Endocrine System Diseases | 1 | 2020 | 282 | 0.16 | Why? |
| Blood Glucose | 4 | 2019 | 3642 | 0.16 | Why? |
| Everolimus | 1 | 2018 | 215 | 0.15 | Why? |
| Reproductive Medicine | 1 | 2018 | 109 | 0.15 | Why? |
| Double-Blind Method | 5 | 2019 | 5988 | 0.15 | Why? |
| Healthy Volunteers | 2 | 2018 | 1444 | 0.15 | Why? |
| Hyperlipidemias | 1 | 2018 | 290 | 0.15 | Why? |
| Sexual Health | 2 | 2020 | 419 | 0.15 | Why? |
| Weight Gain | 1 | 2020 | 552 | 0.15 | Why? |
| Blood Glucose Self-Monitoring | 1 | 2021 | 791 | 0.15 | Why? |
| Physical Fitness | 1 | 2018 | 334 | 0.14 | Why? |
| Platelet-Derived Growth Factor | 1 | 2014 | 21 | 0.14 | Why? |
| Bone Density Conservation Agents | 1 | 2017 | 209 | 0.14 | Why? |
| Body Weight | 2 | 2018 | 1074 | 0.14 | Why? |
| Arginine | 1 | 2017 | 377 | 0.14 | Why? |
| Osteoporotic Fractures | 1 | 2017 | 175 | 0.14 | Why? |
| Aging | 3 | 2019 | 3581 | 0.14 | Why? |
| Surveys and Questionnaires | 5 | 2018 | 43792 | 0.14 | Why? |
| Reproduction | 1 | 2017 | 259 | 0.14 | Why? |
| Prognosis | 10 | 2020 | 32490 | 0.14 | Why? |
| Osteocalcin | 3 | 2018 | 31 | 0.13 | Why? |
| Nutrition Therapy | 1 | 2018 | 285 | 0.13 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.13 | Why? |
| Glomerular Filtration Rate | 2 | 2017 | 1262 | 0.13 | Why? |
| Signal Transduction | 7 | 2020 | 7207 | 0.13 | Why? |
| Drug Administration Schedule | 2 | 2018 | 2324 | 0.13 | Why? |
| Case-Control Studies | 11 | 2019 | 17671 | 0.13 | Why? |
| Plaque, Atherosclerotic | 1 | 2018 | 423 | 0.13 | Why? |
| Dermoscopy | 1 | 2018 | 346 | 0.13 | Why? |
| Penis | 1 | 2014 | 101 | 0.13 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.13 | Why? |
| Thyroid Nodule | 1 | 2014 | 70 | 0.13 | Why? |
| Residential Treatment | 1 | 2014 | 61 | 0.13 | Why? |
| Fetus | 1 | 2017 | 484 | 0.13 | Why? |
| Personality | 1 | 2017 | 277 | 0.13 | Why? |
| Gene Expression Regulation | 4 | 2019 | 4020 | 0.13 | Why? |
| Hyponatremia | 1 | 2017 | 371 | 0.13 | Why? |
| Diabetic Nephropathies | 1 | 2017 | 315 | 0.13 | Why? |
| Nitric Oxide | 1 | 2020 | 769 | 0.13 | Why? |
| Absorptiometry, Photon | 3 | 2019 | 168 | 0.13 | Why? |
| Video Games | 1 | 2017 | 270 | 0.12 | Why? |
| Diabetes Mellitus, Type 1 | 2 | 2018 | 1969 | 0.12 | Why? |
| Pregnancy Rate | 3 | 2018 | 134 | 0.12 | Why? |
| Cell Proliferation | 5 | 2018 | 1973 | 0.12 | Why? |
| Day Care, Medical | 1 | 2014 | 117 | 0.12 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Estradiol | 3 | 2019 | 250 | 0.12 | Why? |
| Prostatectomy | 1 | 2017 | 485 | 0.12 | Why? |
| Checklist | 1 | 2018 | 714 | 0.12 | Why? |
| Geriatric Assessment | 2 | 2018 | 1372 | 0.12 | Why? |
| Aged | 24 | 2021 | 215776 | 0.12 | Why? |
| Sex Characteristics | 2 | 2018 | 1120 | 0.12 | Why? |
| Alopecia | 1 | 2017 | 351 | 0.12 | Why? |
| Selenium | 1 | 2017 | 412 | 0.12 | Why? |
| Ultrasonography | 3 | 2019 | 4409 | 0.12 | Why? |
| Leukocytes, Mononuclear | 2 | 2018 | 2115 | 0.11 | Why? |
| Language | 1 | 2017 | 655 | 0.11 | Why? |
| Exercise Tolerance | 1 | 2017 | 634 | 0.11 | Why? |
| Video Recording | 1 | 2018 | 786 | 0.11 | Why? |
| Thyroid Neoplasms | 1 | 2017 | 422 | 0.11 | Why? |
| Nephrology | 1 | 2017 | 546 | 0.11 | Why? |
| Cancer Survivors | 1 | 2018 | 588 | 0.11 | Why? |
| Genital Neoplasms, Female | 1 | 2018 | 718 | 0.11 | Why? |
| Rehabilitation Centers | 1 | 2014 | 252 | 0.11 | Why? |
| Sports | 1 | 2018 | 690 | 0.11 | Why? |
| Urban Population | 1 | 2021 | 2000 | 0.10 | Why? |
| Reactive Oxygen Species | 2 | 2011 | 1136 | 0.10 | Why? |
| In Vitro Techniques | 3 | 2018 | 1027 | 0.10 | Why? |
| Exercise | 4 | 2018 | 6771 | 0.10 | Why? |
| Membrane Proteins | 2 | 2017 | 1733 | 0.10 | Why? |
| Consensus | 3 | 2020 | 6345 | 0.10 | Why? |
| RNA | 1 | 2017 | 1278 | 0.10 | Why? |
| Sex Hormone-Binding Globulin | 2 | 2019 | 57 | 0.10 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.10 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.10 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.10 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.10 | Why? |
| Young Adult | 13 | 2020 | 93724 | 0.10 | Why? |
| Thyroid Gland | 1 | 2014 | 516 | 0.10 | Why? |
| Cognition | 1 | 2018 | 1394 | 0.10 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.09 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.09 | Why? |
| Cells, Cultured | 5 | 2018 | 5835 | 0.09 | Why? |
| Reproducibility of Results | 4 | 2018 | 11304 | 0.09 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.09 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.09 | Why? |
| Immune System | 1 | 2018 | 1479 | 0.09 | Why? |
| Obesity, Abdominal | 2 | 2021 | 167 | 0.09 | Why? |
| Urogenital Abnormalities | 1 | 2007 | 10 | 0.09 | Why? |
| Inflammation | 4 | 2021 | 13255 | 0.09 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.09 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.09 | Why? |
| Blood Pressure | 2 | 2017 | 2198 | 0.09 | Why? |
| Treatment Outcome | 9 | 2020 | 51732 | 0.09 | Why? |
| Ureter | 1 | 2007 | 59 | 0.08 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2019 | 7268 | 0.08 | Why? |
| Abnormalities, Multiple | 1 | 2007 | 75 | 0.08 | Why? |
| MicroRNAs | 2 | 2019 | 1787 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Adolescent | 10 | 2020 | 86841 | 0.08 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.08 | Why? |
| Phosphoproteins | 1 | 2017 | 4346 | 0.08 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.08 | Why? |
| Hyperglycemia | 1 | 2018 | 1363 | 0.08 | Why? |
| Perception | 1 | 2018 | 2827 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2017 | 3607 | 0.08 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.08 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.08 | Why? |
| Cyclic AMP | 2 | 2018 | 76 | 0.08 | Why? |
| Cytokines | 2 | 2018 | 15010 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.08 | Why? |
| Age of Onset | 2 | 2018 | 557 | 0.08 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.08 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.07 | Why? |
| Calcifediol | 2 | 2017 | 191 | 0.07 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.07 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.07 | Why? |
| Animals | 13 | 2021 | 78931 | 0.07 | Why? |
| Triglycerides | 2 | 2019 | 478 | 0.07 | Why? |
| Image Processing, Computer-Assisted | 1 | 2014 | 1383 | 0.07 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Vitamin D | 2 | 2017 | 2904 | 0.07 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.07 | Why? |
| Sulfones | 1 | 2004 | 66 | 0.07 | Why? |
| Risk Factors | 9 | 2020 | 71621 | 0.07 | Why? |
| Serine Endopeptidases | 1 | 2020 | 4606 | 0.07 | Why? |
| Cholesterol | 2 | 2019 | 660 | 0.07 | Why? |
| Models, Biological | 2 | 2018 | 4907 | 0.07 | Why? |
| Mice | 6 | 2019 | 21357 | 0.06 | Why? |
| Emergency Medical Services | 1 | 2020 | 3557 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.06 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.06 | Why? |
| Oxygen Consumption | 2 | 2018 | 711 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Atherosclerosis | 1 | 2010 | 768 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Fertilization | 1 | 2001 | 49 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Reproductive Techniques | 1 | 2021 | 17 | 0.06 | Why? |
| Cross-Sectional Studies | 6 | 2018 | 53120 | 0.06 | Why? |
| Sperm Banks | 1 | 2020 | 26 | 0.06 | Why? |
| Immunoassay | 1 | 1997 | 4485 | 0.06 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.06 | Why? |
| Medical Oncology | 1 | 2017 | 3826 | 0.05 | Why? |
| Down-Regulation | 2 | 2020 | 1416 | 0.05 | Why? |
| Psychometrics | 2 | 2018 | 1269 | 0.05 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.05 | Why? |
| Diet Surveys | 1 | 2020 | 152 | 0.05 | Why? |
| Receptors, Somatotropin | 1 | 2019 | 8 | 0.05 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.05 | Why? |
| Gene Duplication | 1 | 2019 | 31 | 0.05 | Why? |
| Receptor, TIE-2 | 1 | 2019 | 42 | 0.05 | Why? |
| Industrial Waste | 1 | 2019 | 19 | 0.05 | Why? |
| Protamines | 1 | 2019 | 9 | 0.05 | Why? |
| Predictive Value of Tests | 3 | 2020 | 9537 | 0.05 | Why? |
| Luteinizing Hormone | 1 | 2019 | 91 | 0.05 | Why? |
| Cryoprotective Agents | 1 | 2019 | 19 | 0.05 | Why? |
| Pituitary-Adrenal System | 1 | 2020 | 135 | 0.05 | Why? |
| Octreotide | 1 | 2019 | 56 | 0.05 | Why? |
| Free Radical Scavengers | 1 | 2000 | 82 | 0.05 | Why? |
| Gene Dosage | 1 | 2019 | 101 | 0.05 | Why? |
| Gene Rearrangement | 1 | 2019 | 84 | 0.05 | Why? |
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2018 | 7 | 0.05 | Why? |
| Gels | 1 | 2019 | 111 | 0.05 | Why? |
| Sperm Count | 1 | 2019 | 72 | 0.05 | Why? |
| Cyclic AMP Response Element Modulator | 1 | 2018 | 3 | 0.05 | Why? |
| MEF2 Transcription Factors | 1 | 2018 | 8 | 0.05 | Why? |
| Trisomy | 1 | 2018 | 19 | 0.05 | Why? |
| Transcription Factor AP-2 | 1 | 2018 | 9 | 0.05 | Why? |
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2018 | 13 | 0.05 | Why? |
| Contraindications, Drug | 1 | 2020 | 281 | 0.05 | Why? |
| LIM-Homeodomain Proteins | 1 | 2018 | 7 | 0.05 | Why? |
| Cancellous Bone | 1 | 2018 | 14 | 0.05 | Why? |
| Adipogenesis | 1 | 2018 | 38 | 0.05 | Why? |
| Rome | 1 | 2020 | 497 | 0.05 | Why? |
| Femur Neck | 1 | 2018 | 29 | 0.05 | Why? |
| Sperm Tail | 1 | 2017 | 3 | 0.05 | Why? |
| RANK Ligand | 1 | 2018 | 47 | 0.05 | Why? |
| Vulvar Neoplasms | 1 | 2018 | 59 | 0.05 | Why? |
| Kidney | 2 | 2017 | 3648 | 0.05 | Why? |
| Gastritis | 1 | 2018 | 66 | 0.05 | Why? |
| Morphogenesis | 1 | 2018 | 43 | 0.05 | Why? |
| Pregnancy | 6 | 2019 | 23879 | 0.05 | Why? |
| Administration, Cutaneous | 1 | 2019 | 229 | 0.05 | Why? |
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 47 | 0.05 | Why? |
| T-Box Domain Proteins | 1 | 2018 | 62 | 0.05 | Why? |
| Embryo Culture Techniques | 1 | 2017 | 11 | 0.05 | Why? |
| Vasectomy | 1 | 1997 | 2 | 0.05 | Why? |
| Polystyrenes | 1 | 2019 | 98 | 0.05 | Why? |
| Cell Plasticity | 1 | 2018 | 75 | 0.05 | Why? |
| Glucose Tolerance Test | 1 | 2019 | 238 | 0.05 | Why? |
| Organ Size | 1 | 2019 | 384 | 0.05 | Why? |
| Insulin Receptor Substrate Proteins | 1 | 2017 | 13 | 0.05 | Why? |
| Glucose Transporter Type 4 | 1 | 2017 | 13 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.04 | Why? |
| Ejaculation | 1 | 2017 | 8 | 0.04 | Why? |
| Muscle, Smooth, Vascular | 1 | 2018 | 86 | 0.04 | Why? |
| Time Factors | 6 | 2020 | 31397 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
| Ligation | 1 | 1998 | 84 | 0.04 | Why? |
| Polyploidy | 1 | 2017 | 16 | 0.04 | Why? |
| Purines | 1 | 2004 | 816 | 0.04 | Why? |
| Karyotype | 1 | 2017 | 16 | 0.04 | Why? |
| Myogenin | 1 | 2017 | 4 | 0.04 | Why? |
| Parathyroid Hormone | 1 | 2018 | 98 | 0.04 | Why? |
| Oocyte Retrieval | 1 | 2017 | 44 | 0.04 | Why? |
| Hyperplasia | 1 | 2018 | 204 | 0.04 | Why? |
| 25-Hydroxyvitamin D 2 | 1 | 2017 | 28 | 0.04 | Why? |
| Societies, Medical | 3 | 2020 | 6907 | 0.04 | Why? |
| Stromal Cells | 1 | 2018 | 105 | 0.04 | Why? |
| Cytosol | 1 | 2017 | 77 | 0.04 | Why? |
| Postural Balance | 1 | 2018 | 144 | 0.04 | Why? |
| Glutathione | 1 | 2000 | 280 | 0.04 | Why? |
| Cyclooxygenase Inhibitors | 1 | 2017 | 46 | 0.04 | Why? |
| Caveolin 1 | 1 | 2017 | 73 | 0.04 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2018 | 159 | 0.04 | Why? |
| Testicular Diseases | 1 | 1997 | 35 | 0.04 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.04 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.04 | Why? |
| Femur | 1 | 2018 | 100 | 0.04 | Why? |
| Resistin | 1 | 2016 | 16 | 0.04 | Why? |
| NIH 3T3 Cells | 1 | 2017 | 147 | 0.04 | Why? |
| Subcutaneous Fat | 1 | 2018 | 94 | 0.04 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2018 | 2483 | 0.04 | Why? |
| Peptides, Cyclic | 1 | 2019 | 223 | 0.04 | Why? |
| Embryo Transfer | 1 | 2017 | 91 | 0.04 | Why? |
| Hand Strength | 1 | 2018 | 202 | 0.04 | Why? |
| Islets of Langerhans | 1 | 2018 | 138 | 0.04 | Why? |
| Adipocytes | 1 | 2018 | 173 | 0.04 | Why? |
| Agglutination Tests | 1 | 1997 | 124 | 0.04 | Why? |
| Analysis of Variance | 1 | 2020 | 950 | 0.04 | Why? |
| Gene Deletion | 1 | 2019 | 430 | 0.04 | Why? |
| Endometrial Neoplasms | 1 | 2018 | 120 | 0.04 | Why? |
| Genetic Markers | 1 | 2018 | 318 | 0.04 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2017 | 70 | 0.04 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Hypocalcemia | 1 | 2018 | 120 | 0.04 | Why? |
| Lumbar Vertebrae | 1 | 2018 | 196 | 0.04 | Why? |
| Adiponectin | 1 | 2017 | 123 | 0.04 | Why? |
| Live Birth | 1 | 2017 | 200 | 0.04 | Why? |
| Men's Health | 1 | 2017 | 80 | 0.04 | Why? |
| Placebos | 1 | 2019 | 629 | 0.04 | Why? |
| Protein Isoforms | 1 | 2017 | 347 | 0.04 | Why? |
| Cell Cycle | 1 | 2017 | 329 | 0.04 | Why? |
| Electric Impedance | 1 | 2018 | 283 | 0.04 | Why? |
| Tissue Distribution | 1 | 2017 | 483 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2016 | 335 | 0.04 | Why? |
| Cholesterol, HDL | 1 | 2019 | 439 | 0.04 | Why? |
| Energy Intake | 1 | 2018 | 323 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 1997 | 391 | 0.04 | Why? |
| Prospective Studies | 5 | 2019 | 43301 | 0.04 | Why? |
| Birth Rate | 1 | 2017 | 137 | 0.04 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.04 | Why? |
| Genetic Loci | 1 | 2017 | 439 | 0.04 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.04 | Why? |
| Haplotypes | 1 | 2019 | 853 | 0.04 | Why? |
| Gonadal Steroid Hormones | 1 | 2018 | 328 | 0.04 | Why? |
| Cholesterol, LDL | 1 | 2019 | 499 | 0.04 | Why? |
| Multimorbidity | 1 | 2020 | 703 | 0.04 | Why? |
| Reference Values | 1 | 1998 | 795 | 0.04 | Why? |
| Hypoglycemic Agents | 2 | 2018 | 2165 | 0.04 | Why? |
| Metabolic Diseases | 1 | 2020 | 505 | 0.04 | Why? |
| Albumins | 1 | 2017 | 324 | 0.04 | Why? |
| Cell Membrane | 1 | 2000 | 743 | 0.03 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 502 | 0.03 | Why? |
| Cell Nucleus | 1 | 2017 | 399 | 0.03 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.03 | Why? |
| Receptors, Urokinase Plasminogen Activator | 1 | 2017 | 252 | 0.03 | Why? |
| Retrospective Studies | 7 | 2020 | 105322 | 0.03 | Why? |
| Muscle Contraction | 1 | 2014 | 60 | 0.03 | Why? |
| Gene Frequency | 1 | 2019 | 1210 | 0.03 | Why? |
| Transfection | 1 | 2017 | 864 | 0.03 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
| Metabolome | 1 | 2018 | 624 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.03 | Why? |
| Gene Expression Regulation, Enzymologic | 1 | 2017 | 436 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Antibody Specificity | 1 | 2018 | 1328 | 0.03 | Why? |
| Interleukin-17 | 1 | 2018 | 602 | 0.03 | Why? |
| Vitamin D Deficiency | 2 | 2017 | 1782 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Ovarian Neoplasms | 1 | 2018 | 465 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Respiration | 1 | 2018 | 729 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Gestational Age | 1 | 2018 | 1488 | 0.03 | Why? |
| Transcription Factors | 1 | 2018 | 784 | 0.03 | Why? |
| Rats, Wistar | 1 | 2014 | 621 | 0.03 | Why? |
| Fasting | 1 | 2017 | 555 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Abortion, Spontaneous | 1 | 2017 | 776 | 0.03 | Why? |
| Sarcopenia | 1 | 2017 | 422 | 0.03 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
| Osteoporosis | 1 | 2017 | 410 | 0.03 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2019 | 1316 | 0.03 | Why? |
| Molecular Targeted Therapy | 1 | 2020 | 1579 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2018 | 2739 | 0.03 | Why? |
| Creatinine | 1 | 2017 | 1443 | 0.03 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.03 | Why? |
| Waist Circumference | 1 | 2010 | 199 | 0.03 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.02 | Why? |
| Organizational Innovation | 1 | 2020 | 2468 | 0.02 | Why? |
| Lipids | 1 | 2016 | 1079 | 0.02 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.02 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.02 | Why? |
| Troponin I | 1 | 2018 | 1298 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Observational Studies as Topic | 1 | 2017 | 1887 | 0.02 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.02 | Why? |
| Risk Management | 1 | 2017 | 1044 | 0.02 | Why? |
| Interleukin-6 | 2 | 2017 | 7522 | 0.02 | Why? |
| Hemodynamics | 1 | 2017 | 1562 | 0.02 | Why? |
| Flow Cytometry | 1 | 2017 | 2393 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Seminal Vesicles | 1 | 2007 | 12 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.02 | Why? |
| Feeding Behavior | 1 | 2020 | 1909 | 0.02 | Why? |
| Immunization | 1 | 1997 | 2019 | 0.02 | Why? |
| Diet | 1 | 2020 | 2052 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Smoking | 1 | 2021 | 3358 | 0.02 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.02 | Why? |
| Constriction, Pathologic | 1 | 2007 | 212 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Age Factors | 2 | 2019 | 21039 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.02 | Why? |
| Liver Cirrhosis | 1 | 2017 | 1810 | 0.02 | Why? |
| Neurosurgical Procedures | 1 | 2017 | 1738 | 0.02 | Why? |
| Neurology | 1 | 2017 | 1613 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2016 | 3788 | 0.02 | Why? |
| Echocardiography | 1 | 2019 | 3661 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2014 | 3395 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.02 | Why? |
| Sterilization Reversal | 1 | 1983 | 1 | 0.02 | Why? |
| Hot Temperature | 1 | 1992 | 1299 | 0.02 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Europe | 1 | 2019 | 12702 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Mortality | 1 | 2018 | 7132 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Cell Line | 1 | 2014 | 12040 | 0.01 | Why? |
| Child | 2 | 2018 | 70012 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Occupational Exposure | 1 | 1992 | 4742 | 0.01 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.01 | Why? |
| Interviews as Topic | 1 | 1992 | 1952 | 0.00 | Why? |
| Microsurgery | 1 | 1983 | 166 | 0.00 | Why? |
| Sperm Agglutination | 1 | 1979 | 1 | 0.00 | Why? |
| Oligospermia | 1 | 1979 | 9 | 0.00 | Why? |
| Methylprednisolone | 1 | 1979 | 2107 | 0.00 | Why? |